Keywords: abpi, criticizes, nice, delayin, relenza, issue, following

ABPI criticizes NICE delayin Relenza issue

Article | 22 November 2000

Following the decision by England and Wales' National Institute forClinical Excellence to relax its decision on Glaxo Wellcome's influenza drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Relenza

Zanamivir

Go to drug listing